1-cyclopentyl-6-(((2R)-1-(2-methylpyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

ID: ALA4457086

Chembl Id: CHEMBL4457086

PubChem CID: 155525884

Max Phase: Preclinical

Molecular Formula: C18H26N6O2

Molecular Weight: 358.45

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1CCCN1C(=O)[C@@H](C)Nc1nc2c(cnn2C2CCCC2)c(=O)[nH]1

Standard InChI:  InChI=1S/C18H26N6O2/c1-11-6-5-9-23(11)17(26)12(2)20-18-21-15-14(16(25)22-18)10-19-24(15)13-7-3-4-8-13/h10-13H,3-9H2,1-2H3,(H2,20,21,22,25)/t11?,12-/m1/s1

Standard InChI Key:  YEXTUBISPSAGMY-PIJUOVFKSA-N

Alternative Forms

  1. Parent:

    ALA4457086

    ---

Associated Targets(Human)

PDE1B Tclin Phosphodiesterase 1B (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE9A Tchem Phosphodiesterase 9A (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 358.45Molecular Weight (Monoisotopic): 358.2117AlogP: 2.05#Rotatable Bonds: 4
Polar Surface Area: 95.91Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.56CX Basic pKa: 1.74CX LogP: 1.16CX LogD: 1.16
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.87Np Likeness Score: -1.53

References

1. Wu Y, Zhou Q, Zhang T, Li Z, Chen YP, Zhang P, Yu YF, Geng H, Tian YJ, Zhang C, Wang Y, Chen JW, Chen Y, Luo HB..  (2019)  Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia.,  62  (8): [PMID:30916555] [10.1021/acs.jmedchem.8b01041]

Source